HIVe Home
HIV VACCINE ELECTRONIC (E) RESOURCE
Posted: 13 Jul 2012
 

Latest research highlights: New microbicide delivery system, EAT-2 is a powerful gene-based adjuvant, infection with a harmless virus improves HIV prognosis, escape from bNabs, and immunization of newborns

READ MORE
Posted: 22 Jun 2012
 

Latest research highlights: Better nanoparticles for mucosal delivery, breast milk antibodies mediate ADCC, certain T cell clonotypes are better at protection, B cells facilitate T cell responses, reviews of elite controllers and of the MF59 adjuvant mode of action

READ MORE
Posted: 11 Jun 2012
 

Latest research highlights: Transmitter viruses are not functionally different from chronic, early antibodies drive HIV evolution, neutralization does not correlate with protection in clinical trials, new and improved SHIV, review of interplay between NK and HIV

READ MORE
Posted: 31 May 2012
 

Latest research highlights: Early CD8 inhibit HIV, recognition of HIV by NK cellsis mediated by IgG, review of immune dysfunction during HIV infection and latest data on IL-10 contributes to it, size of Th17 compartment predicts viral load

READ MORE
Posted: 23 May 2012
 

Latest research highlights: rAd5/rLCMV vaccine protects against heterologous challenge in NHPs, HIV adapts to foil antigen processing, role of autophagy in HIV infection, NeutNet Phase II report, microbicide/vaccine combination tested in NHPs, NIH reports on October 2011 carbohydrate workshop.

READ MORE